STOCK TITAN

[25-NSE] Mynaric AG SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
25-NSE
Rhea-AI Filing Summary

Mynaric AG has submitted Form 25-NSE to notify its removal from listing and/or registration on the Nasdaq Stock Market LLC. The delisting affects the company's American Depository Shares (ADS).

Key details of the notification:

  • Filing Date: June 28, 2025
  • Commission File Number: 001-41045
  • Company headquarters: Gilching, Germany
  • The delisting process is being conducted pursuant to Exchange rules and requirements under 17 CFR 240.12d2-2(b)

The Form 25 was signed by Aravind Menon, Hearings Advisor, on June 23, 2025. This delisting action represents a significant change in Mynaric's market presence and accessibility to U.S. investors, as it will no longer be traded on the Nasdaq exchange.

Mynaric AG ha presentato il Modulo 25-NSE per notificare la sua rimozione dalla quotazione e/o registrazione presso il Nasdaq Stock Market LLC. La cancellazione riguarda le American Depository Shares (ADS) della società.

Dettagli principali della notifica:

  • Data di presentazione: 28 giugno 2025
  • Numero di protocollo della Commissione: 001-41045
  • Sede centrale della società: Gilching, Germania
  • Il processo di cancellazione è effettuato in conformità alle regole e ai requisiti dell’Exchange secondo il 17 CFR 240.12d2-2(b)

Il Modulo 25 è stato firmato da Aravind Menon, Consulente per le Audizioni, il 23 giugno 2025. Questa azione di delisting rappresenta un cambiamento significativo nella presenza di Mynaric sul mercato e nella sua accessibilità per gli investitori statunitensi, poiché non sarà più negoziata sul Nasdaq.

Mynaric AG ha presentado el Formulario 25-NSE para notificar su exclusión de la cotización y/o registro en el Nasdaq Stock Market LLC. La exclusión afecta a las American Depository Shares (ADS) de la compañía.

Detalles clave de la notificación:

  • Fecha de presentación: 28 de junio de 2025
  • Número de expediente de la Comisión: 001-41045
  • Sede de la empresa: Gilching, Alemania
  • El proceso de exclusión se realiza conforme a las normas y requisitos del Exchange bajo 17 CFR 240.12d2-2(b)

El Formulario 25 fue firmado por Aravind Menon, Asesor de Audiencias, el 23 de junio de 2025. Esta acción de exclusión representa un cambio significativo en la presencia de Mynaric en el mercado y su accesibilidad para los inversores estadounidenses, ya que dejará de cotizar en el Nasdaq.

Mynaric AG는 나스닥 증권거래소 LLC에서 상장 및/또는 등록 해제를 알리기 위해 Form 25-NSE를 제출했습니다. 이번 상장폐지는 회사의 미국예탁증서(ADS)에 영향을 미칩니다.

알림 주요 사항:

  • 제출일: 2025년 6월 28일
  • 증권거래위원회 파일 번호: 001-41045
  • 회사 본사: 독일 길칭(Gilching)
  • 상장폐지 절차는 17 CFR 240.12d2-2(b)에 따른 거래소 규칙 및 요구사항에 따라 진행됩니다.

Form 25는 Aravind Menon 청문 자문관이 2025년 6월 23일 서명했습니다. 이번 상장폐지 조치는 Mynaric의 시장 존재감과 미국 투자자 접근성에 중대한 변화를 의미하며, 앞으로 나스닥 거래소에서 거래되지 않게 됩니다.

Mynaric AG a soumis le formulaire 25-NSE pour notifier sa radiation de la cotation et/ou de l’enregistrement sur le Nasdaq Stock Market LLC. Cette radiation concerne les American Depository Shares (ADS) de la société.

Détails clés de la notification :

  • Date de dépôt : 28 juin 2025
  • Numéro de dossier de la Commission : 001-41045
  • Siège social de l’entreprise : Gilching, Allemagne
  • Le processus de radiation est effectué conformément aux règles et exigences de la Bourse selon le 17 CFR 240.12d2-2(b)

Le formulaire 25 a été signé par Aravind Menon, conseiller aux audiences, le 23 juin 2025. Cette décision de radiation représente un changement important dans la présence de Mynaric sur le marché et son accessibilité aux investisseurs américains, car elle ne sera plus négociée sur le Nasdaq.

Mynaric AG hat das Formular 25-NSE eingereicht, um die Entfernung von der Notierung und/oder Registrierung an der Nasdaq Stock Market LLC zu melden. Die Delistung betrifft die American Depository Shares (ADS) des Unternehmens.

Wichtige Details der Mitteilung:

  • Einreichungsdatum: 28. Juni 2025
  • Aktenzeichen der Kommission: 001-41045
  • Firmensitz: Gilching, Deutschland
  • Der Delisting-Prozess erfolgt gemäß den Börsenregeln und Anforderungen nach 17 CFR 240.12d2-2(b)

Das Formular 25 wurde am 23. Juni 2025 von Aravind Menon, Anhörungsberater, unterzeichnet. Diese Delisting-Maßnahme stellt eine bedeutende Veränderung der Marktpräsenz von Mynaric und deren Zugänglichkeit für US-Investoren dar, da die Aktie künftig nicht mehr an der Nasdaq gehandelt wird.

Positive
  • None.
Negative
  • Mynaric AG is being delisted from the Nasdaq Stock Market, which significantly reduces trading liquidity and accessibility for U.S. investors
  • Delisting often indicates financial or regulatory compliance issues and may make it more difficult for the company to raise capital in the future

Mynaric AG ha presentato il Modulo 25-NSE per notificare la sua rimozione dalla quotazione e/o registrazione presso il Nasdaq Stock Market LLC. La cancellazione riguarda le American Depository Shares (ADS) della società.

Dettagli principali della notifica:

  • Data di presentazione: 28 giugno 2025
  • Numero di protocollo della Commissione: 001-41045
  • Sede centrale della società: Gilching, Germania
  • Il processo di cancellazione è effettuato in conformità alle regole e ai requisiti dell’Exchange secondo il 17 CFR 240.12d2-2(b)

Il Modulo 25 è stato firmato da Aravind Menon, Consulente per le Audizioni, il 23 giugno 2025. Questa azione di delisting rappresenta un cambiamento significativo nella presenza di Mynaric sul mercato e nella sua accessibilità per gli investitori statunitensi, poiché non sarà più negoziata sul Nasdaq.

Mynaric AG ha presentado el Formulario 25-NSE para notificar su exclusión de la cotización y/o registro en el Nasdaq Stock Market LLC. La exclusión afecta a las American Depository Shares (ADS) de la compañía.

Detalles clave de la notificación:

  • Fecha de presentación: 28 de junio de 2025
  • Número de expediente de la Comisión: 001-41045
  • Sede de la empresa: Gilching, Alemania
  • El proceso de exclusión se realiza conforme a las normas y requisitos del Exchange bajo 17 CFR 240.12d2-2(b)

El Formulario 25 fue firmado por Aravind Menon, Asesor de Audiencias, el 23 de junio de 2025. Esta acción de exclusión representa un cambio significativo en la presencia de Mynaric en el mercado y su accesibilidad para los inversores estadounidenses, ya que dejará de cotizar en el Nasdaq.

Mynaric AG는 나스닥 증권거래소 LLC에서 상장 및/또는 등록 해제를 알리기 위해 Form 25-NSE를 제출했습니다. 이번 상장폐지는 회사의 미국예탁증서(ADS)에 영향을 미칩니다.

알림 주요 사항:

  • 제출일: 2025년 6월 28일
  • 증권거래위원회 파일 번호: 001-41045
  • 회사 본사: 독일 길칭(Gilching)
  • 상장폐지 절차는 17 CFR 240.12d2-2(b)에 따른 거래소 규칙 및 요구사항에 따라 진행됩니다.

Form 25는 Aravind Menon 청문 자문관이 2025년 6월 23일 서명했습니다. 이번 상장폐지 조치는 Mynaric의 시장 존재감과 미국 투자자 접근성에 중대한 변화를 의미하며, 앞으로 나스닥 거래소에서 거래되지 않게 됩니다.

Mynaric AG a soumis le formulaire 25-NSE pour notifier sa radiation de la cotation et/ou de l’enregistrement sur le Nasdaq Stock Market LLC. Cette radiation concerne les American Depository Shares (ADS) de la société.

Détails clés de la notification :

  • Date de dépôt : 28 juin 2025
  • Numéro de dossier de la Commission : 001-41045
  • Siège social de l’entreprise : Gilching, Allemagne
  • Le processus de radiation est effectué conformément aux règles et exigences de la Bourse selon le 17 CFR 240.12d2-2(b)

Le formulaire 25 a été signé par Aravind Menon, conseiller aux audiences, le 23 juin 2025. Cette décision de radiation représente un changement important dans la présence de Mynaric sur le marché et son accessibilité aux investisseurs américains, car elle ne sera plus négociée sur le Nasdaq.

Mynaric AG hat das Formular 25-NSE eingereicht, um die Entfernung von der Notierung und/oder Registrierung an der Nasdaq Stock Market LLC zu melden. Die Delistung betrifft die American Depository Shares (ADS) des Unternehmens.

Wichtige Details der Mitteilung:

  • Einreichungsdatum: 28. Juni 2025
  • Aktenzeichen der Kommission: 001-41045
  • Firmensitz: Gilching, Deutschland
  • Der Delisting-Prozess erfolgt gemäß den Börsenregeln und Anforderungen nach 17 CFR 240.12d2-2(b)

Das Formular 25 wurde am 23. Juni 2025 von Aravind Menon, Anhörungsberater, unterzeichnet. Diese Delisting-Maßnahme stellt eine bedeutende Veränderung der Marktpräsenz von Mynaric und deren Zugänglichkeit für US-Investoren dar, da die Aktie künftig nicht mehr an der Nasdaq gehandelt wird.

UNITED STATES
OMB APPROVAL
OMB Number: 3235-0080
Expires: March 31, 2018
Estimated average burden
hours per response: 1.7
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-41045
Issuer: Mynaric AG
Exchange: Nasdaq Stock Market LLC
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address: Dornierstrabe 19
Gilching GERMANY 82205
Telephone number: +49 8105 7999 106
(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
American Depository Shares
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
17 CFR 240.12d2-2(a)(1)
17 CFR 240.12d2-2(a)(2)
17 CFR 240.12d2-2(a)(3)
17 CFR 240.12d2-2(a)(4)
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2025-06-23 By Aravind Menon Hearings Advisor
Date Name Title
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Why is Mynaric AG (MYNA) being delisted from Nasdaq?

According to the Form 25 filing dated June 28, 2025, Mynaric AG (MYNA) is being removed from listing on the Nasdaq Stock Market LLC. The filing indicates this action is being taken under Exchange rules, as certified by Nasdaq's Hearings Advisor Aravind Menon on June 23, 2025.

What happens to MYNA's American Depositary Shares after delisting?

The Form 25 filing specifically concerns MYNA's American Depositary Shares being removed from listing and registration under Section 12(b) of the Securities Exchange Act of 1934. After delisting, these shares will no longer trade on the Nasdaq Stock Market LLC.

Where is Mynaric AG's principal office located?

According to the Form 25 filing, Mynaric AG's principal office is located at Dornierstrabe 19, Gilching, GERMANY 82205. The company's telephone number is listed as +49 8105 7999 106.

When did Nasdaq file the Form 25 for MYNA's delisting?

The Form 25 for MYNA's delisting was signed by Nasdaq's Hearings Advisor on June 23, 2025, and officially filed with the SEC on June 28, 2025. This notification serves as formal documentation of the stock's removal from listing and registration on the Nasdaq Stock Market LLC.
Mynaric Ag

NASDAQ:MYNA

MYNA Rankings

MYNA Latest News

MYNA Stock Data

11.15M
25.27M
0.02%
12.28%
0.33%
Communication Equipment
Technology
Link
Germany
Munich